https://www.selleckchem.com/pr....oducts/Staurosporine
21, p=0.001). DTC was not different between groups. Higher NSI somatic sub-score was related to higher single- and dual-task gait variability as well as slower dual-task pace and turning (p less then 0.01). People with chronic mTBI and persistent symptoms exhibited altered gait, particularly under dual-task, and worse gait performance related to greater symptom severity. Future gait research in chronic mTBI should assess the possible underlying physiological mechanisms for persistent symptoms and gait deficits.Malingered attention
Beğen
Yorum Yap
Paylaş
